Navigation Links
NovaQuest Advances 'Virtual Development' Model With Strategic Investment in TOPIGEN Pharmaceuticals
Date:8/27/2007

RESEARCH TRIANGLE PARK, N.C., Aug. 27 /PRNewswire/ -- NovaQuest has made a strategic investment in TOPIGEN Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company specializing in respiratory disorders. The investment was part of a private placement of C$26 million (US$25 million) in the Montreal-based company.

Last week's The investment by NovaQuest, the strategic partnering group of Quintiles Transnational, helps TOPIGEN accelerate its Phase II lead-product clinical programs. NovaQuest and Quintiles first provided strategic product development advice to TOPIGEN three years ago; the relationship has since evolved into an integrated development partnership.

Patricia Lamothe, TOPIGEN's Chief Financial Officer, said: "The ability to access NovaQuest's clinical expertise and Quintiles' development capabilities is a tremendous benefit to our company as we continue to advance our product candidates for significant breakthroughs in the treatment of respiratory diseases."

NovaQuest Vice President Ben Cons, Ph.D., said: "Having been very active in 2006, with 16 strategic investments, our focus now is to create fewer but larger partnerships. We're seeking high potential biotechs -- those with excellent pipelines and strong management teams. Our managed partnership with TOPIGEN is an example of this.

"We believe that NovaQuest's strong clinical experience and intellectual capital, backed by Quintiles' global development resources, is a great fit to help TOPIGEN advance its clinical candidates efficiently and strategically."

In November NovaQuest made a strategic investment in Canadian biotech company BioMS Medical Corp. (TSX: MS), a leading developer in the treatment of multiple sclerosis. For all of 2006, NovaQuest participated as a minority investor in funding rounds that raised a total of $342 million for 16 emerging biotechnology companies worldwide.

NovaQuest, the strategic partnering group of Quintiles Transnational, i
'/>"/>

SOURCE NovaQuest
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. The Affymetrix GeneChip Scanner 3000 New Advances in Scanner Design for Superior Performance, Reliability, and Dynamic Range
2. Quintessence Biosciences advances cancer drug
3. Healthcare slow to adopt genetic advances
4. Wireless advances in Madison, heats up in Waukesha
5. GE Healthcares CT Scanner advances coronary imaging
6. Cancer treatment advances as trials show no harm to mice
7. New CT scanner by GE Healthcare advances imaging technology
8. Small wonders: Intersection of biotech and nanotech will produce big advances
9. Standards Needed for Advances in Healthcare Technology
10. Virtual communities make online connections
11. Virtual-reality welding simulator an opportunity for Chippewa Valley college
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2015)... uBiome, the leading startup focused ... PicnicHealth, a healthcare company that collects and consolidates ... Bowel Disease (IBD) will receive a complementary PicnicHealth ... kit. Both companies were funded by Y Combinator ... more information on this partnership and how to ...
(Date:5/21/2015)... May 21, 2015  CytRx Corporation (NASDAQ: ... specializing in oncology, today announced positive updated results ... aldoxorubicin for the treatment of unresectable glioblastoma multiforme ... open-label, multisite trial is designed to investigate the ... whose tumors have progressed following prior treatment with ...
(Date:5/21/2015)... 2015 Tunnell Consulting, Inc. ... as senior statistician and Principal, a position to which ... the management and analysis of complex and large data ... , “We’re delighted to have Julia join the Tunnell ... said Dr. Philippe Cini, Group Vice President and leader ...
(Date:5/20/2015)... , May 20, 2015  Select Medical Corporation ... Federal Trade Commission granted early termination of the ... Act of 1976, as amended, applicable to the ... Corporation, a joint venture that Select has created ... As previously announced, MJ Acquisition Corporation has ...
Breaking Biology Technology:uBiome Partners with PicnicHealth 2uBiome Partners with PicnicHealth 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 2CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 3CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 4CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 5CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 6CytRx Reports Positive Updated Phase 2 Aldoxorubicin Clinical Trial Results in Glioblastoma Multiforme (Brain Cancer) 7Julia O’Neill Joins Tunnell Consulting’s Operational and Process Improvement Practice 2Select Medical Corporation's Proposed Acquisition of Concentra Inc. through Joint Venture with Welsh Carson Receives Antitrust Clearance 2
... released its upcoming schedule of CLE accredited,teleconferences for tort litigators, ... , , Upcoming teleconferences include:, ... the State of the Art., February ... February 5 - Nanotechnology: Is it the Next Plastics or ...
... NEW YORK, Jan. 20 Immtech Pharmaceuticals, Inc. ... Company has appointed Virchow, Krause & Company, LLP ... immediately. The decision to change the Company,s independent ... Company,s board of directors. The appointment will ...
... REYKJAVIK, Iceland, Jan. 20 deCODE genetics (Nasdaq: ... agreement with NBI, an Icelandic financial institution, pursuant to which ... price of $11 million. Pursuant to the agreement, deCODE has ... back to the company at any time prior to December ...
Cached Biology Technology:Asbestos, Pharmaceutical Liability, Construction Defects, Nanotech: Covered by Targeted CLE Teleconferences 2Immtech Announces Appointment of Virchow Krause as Independent Registered Public Accounting Firm 2deCODE Sells Auction Rate Securities 2deCODE Sells Auction Rate Securities 3
(Date:5/11/2015)... 2015  Synaptics Incorporated (NASDAQ: SYNA ), ... announced the appointment of Wajid Ali ... reporting to Rick Bergman , President and ... Officer, Kathleen Bayless , who announced her ... Ali brings extensive financial management expertise to Synaptics, ...
(Date:5/8/2015)... -- Synaptics Inc. (NASDAQ: SYNA ), the leading developer ... executive management team will present at the following investor events: ... Conference Date: May 18, 2015 Time: 10:40am ET ... Cowen and Company Technology, Media & Telecom ... New York Palace Hotel, New York, NY ...
(Date:4/27/2015)... 27, 2015  For more than four decades, AUVSI,s ... been the premier worldwide event for the unmanned land, ... must-attend event for any local, national, or trade news ... commercial markets and current applications of unmanned technologies. The ... projected $48 billion industry, and how it will soon ...
Breaking Biology News(10 mins):Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Synaptics to Present at Upcoming Investor Conferences 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 2UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 3UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 4UNMANNED SYSTEMS 2015: Largest International Conference and Trade Show for the Drone and Unmanned Technology Industry 5
... genetic techniques led by Adelaide researchers are making it ... protected rainforests. DNA fingerprinting for timber products has ... the University of Adelaide that traces individual ... they came from. Professor Andrew Lowe, Director of ...
... the Institute of Food Research and The Genome Analysis ... bacterium, to help understand how these organisms evolved their ... gut bacteria and the gastrointestinal tract is one of ... of bacteria in establishing and maintaining gut health is ...
... think nicotine receptors are only important to smokers trying ... published in the FASEB Journal ( http://www.fasebj.org ... role in social interaction and the ability to choose ... the nicotinic receptors in the prefrontal cortex are essential ...
Cached Biology News:Using DNA in fight against illegal logging 2Genome analysis will reveal how bacteria in our guts make themselves at home 2Your brain on nicotine: Nicotine receptors affect social behavior 2
Monoclonal antibodies conjugated with rhodamine...
... to Rhodopsin Rhodopsin is a glycoprotein ... birds, amphibians, and reptiles. The rhodopsin protein ... the retina. Immunogen: Membrane ... Specificity: This antibody specifically labels the ...
... 3′-(α-Amino- p- methoxyhydrocinnamamido)-3′-deoxy-N,N-dimethyladenosine, 2HCl ... PROTECT FROM MOISTURE. Protein synthesis inhibitor. ... of nascent polypeptide chains. Induces DNA ... HL-60 leukemia cells. Purity: ≥98% ...
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Biology Products: